Table 1.
Patients prescribed each medication for those with CVD/HF and/or CKD and those without
| CVD/HF and/or CKD | No CVD/HF/CKD | Total N with medication prescribed | |
|---|---|---|---|
| Medication | N (% of comorbidity group) | ||
| SGLT2i* | 161 (14.9) | 701 (21.2) | 862 |
| GLP-1RA* | 50 (4.6) | 363 (11.0) | 413 |
| Metformin/Biguanide | 828 (76.8) | 2573 (78.0) | 3401 |
| Insulin secretagogues* | 304 (28.2) | 729 (22.1) | 1033 |
| DPP4i* | 240 (22.3) | 603 (18.3) | 843 |
| Insulin* | 330 (30.6) | 747 (22.6) | 1077 |
| Total in comorbidity group | 1078 | 3299 | 4377 |
Used to indicate a significant difference between both comorbidity groups at p < 0.05